Joel Isaacson & Co., LLC Acelrx Pharmaceuticals Inc Transaction History

Joel Isaacson & Co., LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 18, 2019	SELL	$2.13 - $4.8 $42,600 - $96,000	-20,000 Closed	0 $0
Q2 2018 Aug 01, 2018	SELL	$2.13 - $4.2 $85,200 - $168,000	-40,000 Reduced 66.67%	20,000 $68,000
Q1 2018 May 01, 2018	SELL	$1.7 - $2.35 $17,000 - $23,500	-10,000 Reduced 14.29%	60,000 $126,000
Q4 2017 Jan 30, 2018	SELL	$1.75 - $5.5 $1,155 - $3,630	-660 Reduced 0.93%	70,000 $142,000
Q3 2017 Nov 02, 2017	BUY	$2.9 - $4.6 $204,914 - $325,036	70,660	70,660 $325,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Joel Isaacson & Co., LLC, based on Form 13F filings with the SEC.

Stay updated on Joel Isaacson & Co., LLC with notifications on news.